Cancer Prevention


Spring 2006
Issue 7


Past Issue Archive
Calendar of Events
May
 
World No Tobacco Day
 
June
 
National Men's Health Week
 
September
 
Ovarian Cancer Awareness Month
 
 
Prostate Cancer Awareness Month
 
October
 
Healthy Lung Month
 
November
 
Cancer Prevention | Issue Seven


[In Feature]
Aging and CancerAging and Cancer
A Timeless Concern for Prevention Efforts
Although cancer occurs at all ages, the highest incidence and mortality rates occur in those over 65 years of age. Research continues to assess the best prevention and early detection efforts in this age group. [more]
 
Nicotine Vaccine: A Promising Treatment for Nicotine AddictionNicotine Vaccine: A Promising Treatment for Nicotine Addiction
Unfortunately, for many people Mark Twain’s quip about quitting smoking is a frustrating reality. Nicotine, a naturally found drug in tobacco, is the culprit. The person becomes physically and psychologically dependent on this substance, which can be as addictive as cocaine or heroin when inhaled, making it very difficult to give up smoking. [more]
 
Promoting a State of Prevention
The Pennsylvania Cancer Control Consortium (PAC3) is an initiative formed in 2001 to reduce the human and economic burden of cancer by creating the first-ever Pennsylvania Comprehensive Cancer Control Plan. PAC3 represents more than 800 individuals and 250 public, private, academic, and volunteer organizations and is based on the premise that working together is the only way to develop an effective plan for cancer control. [more]
 
Smoke-Free Workplace States
Washington is the ninth state to adopt a comprehensive, statewide smoke-free workplace law that includes restaurants and bars. [more]
 
Cervical Cancer Vaccine May Be on the Horizon
Human papillomavirus (HPV) has been identified as the cause of cervical cancer, pre-cancers, benign cervical lesions, and genital warts. [more]
Cancer Prevention Mailing List
Sign up for the Cancer Prevention Online Newsletter mailing list.
First Name:  
Last Name:
E-mail:
E-mail Confirmation:
Zip/Postal Code:
The Drive Against Prostate Cancer
Too busy to go for a prostate screening? Well, prostate cancer screening may be coming to you. The National Prostate Cancer Coalition's (NPCC) 39-foot mobile screening unit tours the US to offer free screenings — prostate-specific antigen (PSA) blood test) and a digital rectal exam (DRE). About 10,000 men take advantage of this opportunity every year. Check out the NPCC's Web site to see when the screening will be in your area.
[In Letter from the Editors]
Letter From the Editors
The field of cancer prevention focuses on trying to find risk factors for cancer that can be avoided or modified. The one omnipresent and inevitable risk factor to which all of us are subject is age. [more]
[In News from the NCI]
News from the NCI
Centers of Cancer Nanotechnology Excellence Think Small to Make Big Changes in Cancer Prevention, Diagnosis and Treatment
The NCI recently awarded funding to establish eight Centers of Cancer Nanotechnology Excellence (CCNEs). Through these programs, researchers will harness the power of nanotechnology and apply it to the major challenges of basic research and clinical oncology to improve early detection, diagnosis and treatment of cancer. [more]
[In Clinical]
Cancer Prevention Clinical Trials
If you are interested in learning more about a trial, access the Web site address or call the phone number provided for additional information. [more]
Cancer Prevention Legislation
[In Legislation]
State Legislation
Legislation pertaining to cancer and its prevention that is under consideration in various states. [more]
 
Federal Legislation
Federal legislation pertaining to cancer and its prevention that is under consideration in the US Congress. [more]
[In Additional Information]
Make Your Voice HeardMake Your Voice Heard
Contact your Congressional representatives, the White House, or other government agencies to express your support of cancer prevention legislation and to urge the funding of cancer prevention research. [more]
 
Other Information Resources
[more]
2005 Nobel Prize in Physiology or Medicine Recognizes Research on H. Pylori
Australian researchers J. Robin Warren and Barry Marshall were awarded the recent Nobel Prize in Physiology or Medicine for their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease. This discovery has led to an increased understanding of the connection between chronic infection, inflammation, and cancer. The severity of the inflammation that results from H. pylori infection in the stomach is of crucial importance for the diseases that can result. In some people, H. pylori infects the corpus region of the stomach, resulting in a widespread inflammation that predisposes the person not only to peptic ulcer disease, but also to stomach cancer. Although the incidence of this particular malignancy has decreased in many developed countries during the past 50 years, it still ranks among the most common malignancies worldwide, with over 850,000 cases and 650,000 deaths each year.
 
Back to Top
 
NewYork-Presbyterian. The University Hospitals of Columbia and Cornell